Towards national paediatric clinical practice guidelines

IF 6.7 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Kelvin Hill, Steven McGloughlin, Sharon McGowan, Tari Turner
{"title":"Towards national paediatric clinical practice guidelines","authors":"Kelvin Hill,&nbsp;Steven McGloughlin,&nbsp;Sharon McGowan,&nbsp;Tari Turner","doi":"10.5694/mja2.52500","DOIUrl":null,"url":null,"abstract":"<p><span>To the Editor:</span> It is encouraging to hear the collaborative effort in paediatric clinical practice guidelines (CPGs).<span><sup>1</sup></span> CPGs provide a critical tool for clinicians, health administrators and policy makers. We strongly agree that nationally coordinated efforts for evidence synthesis are clearly needed, which can be adapted if required. Starr<span><sup>1</sup></span> also makes important points around suboptimal adherence to CPGs, including lack of currency and concerns on evidence quality. Evidence is rapidly evolving and previous analysis found that one in five clinical practice recommendations were out of date within three years.<span><sup>2</sup></span> Fortunately, Australia has pioneered living guideline methods, which use frequent (1–3 monthly) surveillance systems and rapid response pathways using robust Grading of Recommendations Assessment, Development and Evaluation (GRADE) methods to ensure recommendations are up to date.<span><sup>3</sup></span> This new model is clearly feasible and has demonstrated an increase in trust, frequency of access and intention to apply advice by stakeholders, in areas as diverse as coronavirus disease 2019 and stroke.<span><sup>4, 5</sup></span> Our experience, contrasting to Starr's, is that this approach is feasible and helpful to develop living guidelines that use reliable GRADE methods and meet National Health and Medical Research Council standards. Living methods (using GRADE) are now considered the gold standard by leading guideline developers such as the National Institute for Health and Care Excellence in England and the World Health Organization. Unfortunately, in Australia there is no national agency to prioritise what guidelines should be developed, let alone sustainable funding to ensure they are kept up to date. We agree with Starr that this must urgently change and call on all governments to invest in CPG infrastructure and capacity. In an age of widespread misinformation and disinformation, it is crucial that Australian clinicians, patients and policy makers have access to reliable, up-to-date, evidence-based information to enable the best possible health care decisions.</p><p>All authors are members of the Australian Living Evidence Collaboration Strategic Advisory Committee.</p>","PeriodicalId":18214,"journal":{"name":"Medical Journal of Australia","volume":"221 10","pages":"564"},"PeriodicalIF":6.7000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.5694/mja2.52500","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Journal of Australia","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.5694/mja2.52500","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

To the Editor: It is encouraging to hear the collaborative effort in paediatric clinical practice guidelines (CPGs).1 CPGs provide a critical tool for clinicians, health administrators and policy makers. We strongly agree that nationally coordinated efforts for evidence synthesis are clearly needed, which can be adapted if required. Starr1 also makes important points around suboptimal adherence to CPGs, including lack of currency and concerns on evidence quality. Evidence is rapidly evolving and previous analysis found that one in five clinical practice recommendations were out of date within three years.2 Fortunately, Australia has pioneered living guideline methods, which use frequent (1–3 monthly) surveillance systems and rapid response pathways using robust Grading of Recommendations Assessment, Development and Evaluation (GRADE) methods to ensure recommendations are up to date.3 This new model is clearly feasible and has demonstrated an increase in trust, frequency of access and intention to apply advice by stakeholders, in areas as diverse as coronavirus disease 2019 and stroke.4, 5 Our experience, contrasting to Starr's, is that this approach is feasible and helpful to develop living guidelines that use reliable GRADE methods and meet National Health and Medical Research Council standards. Living methods (using GRADE) are now considered the gold standard by leading guideline developers such as the National Institute for Health and Care Excellence in England and the World Health Organization. Unfortunately, in Australia there is no national agency to prioritise what guidelines should be developed, let alone sustainable funding to ensure they are kept up to date. We agree with Starr that this must urgently change and call on all governments to invest in CPG infrastructure and capacity. In an age of widespread misinformation and disinformation, it is crucial that Australian clinicians, patients and policy makers have access to reliable, up-to-date, evidence-based information to enable the best possible health care decisions.

All authors are members of the Australian Living Evidence Collaboration Strategic Advisory Committee.

制定国家儿科临床实践指南。
致编辑:儿科临床实践指南(CPGs)1 的合作努力令人鼓舞。1 CPG 为临床医生、健康管理者和政策制定者提供了重要工具。我们非常同意,显然需要在全国范围内协调开展证据综合工作,如有需要,可对其进行调整。Starr1 还就 CPGs 的不理想遵守情况提出了重要观点,包括缺乏时效性和对证据质量的担忧。2 幸运的是,澳大利亚率先采用了 "活指南 "方法,利用频繁(1-3 个月)的监测系统和快速反应途径,采用可靠的 "建议评估、发展和评价分级"(GRADE)方法,确保建议的时效性。这种新模式显然是可行的,并已证明在 2019 年冠状病毒疾病和中风等不同领域,利益相关者的信任度、获取频率和应用建议的意愿都有所提高。目前,英国国家健康与护理卓越研究所(National Institute for Health and Care Excellence)和世界卫生组织(World Health Organization)等领先的指南制定者都将活用方法(使用 GRADE)视为黄金标准。遗憾的是,澳大利亚没有一个国家机构来确定制定指南的优先次序,更不用说提供可持续的资金来确保指南的及时更新。我们同意斯塔尔的观点,认为必须立即改变这种状况,并呼吁各国政府投资于 CPG 基础设施和能力建设。在错误信息和虚假信息泛滥的时代,澳大利亚的临床医生、患者和政策制定者必须能够获得可靠的、最新的、以证据为基础的信息,从而做出最佳的医疗决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical Journal of Australia
Medical Journal of Australia 医学-医学:内科
CiteScore
9.40
自引率
5.30%
发文量
410
审稿时长
3-8 weeks
期刊介绍: The Medical Journal of Australia (MJA) stands as Australia's foremost general medical journal, leading the dissemination of high-quality research and commentary to shape health policy and influence medical practices within the country. Under the leadership of Professor Virginia Barbour, the expert editorial team at MJA is dedicated to providing authors with a constructive and collaborative peer-review and publication process. Established in 1914, the MJA has evolved into a modern journal that upholds its founding values, maintaining a commitment to supporting the medical profession by delivering high-quality and pertinent information essential to medical practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信